stockrow
Saturday 7 November 2026
Export PLRZ’s income statement to Excel — free account
Polyrizon Ltd.
PLRZ Healthcare Biotechnology
11.05
0.54
−4.66%
Follow PLRZ
Alert me
Polyrizon Ltd. (PLRZ) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ACET Adicet Bio, Inc. compare | n/m |
| ANVS Annovis Bio, Inc. compare | n/m |
| ALGS Aligos Therapeutics, Inc. compare | n/m |
| ABVC ABVC BioPharma, Inc. compare | n/m |
| BCTX BRIACELL THERAP compare | n/m |
| MGX Metagenomi Therapeutics, Inc. compare | n/m |
| BYSI BeyondSpring Inc. compare | n/m |
| EDSA Edesa Biotech, Inc. compare | n/m |
| PLRZ Polyrizon Ltd. | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)